In the “never bet against science” category, this week we examine the early results of a gene-editing research study that looks to have permanently reduced LDL and triglyceride levels in monkeys. These two markers are key factors in heart disease, and this foundational research could one day ultimately provide a cure for heart disease. Potentially a big deal. Next, we take a look at Lululemon’s recent acquisition of Mirror as Lulu looks to expand its in-home fitness and workout portfolio. Finally, we review a home fitness app that dubs itself as the “world’s smartest personal trainer.” We’ll see how it stacks up and how it helps you stack on track with your fitness goals.
#heartdisease #triglycerides #LDL #lululemon #mirror #homefitness #homeworkout #onyxapp
A "Cure for Heart Disease"?
Lululemon Buys Mirror for $500M
Onyx Home Workout App
- Summary of Onyx App
References and Links from Episode 68:
Verve Therapeutics - Gene Editing
Beam Therapeutics Gene Editing Platform
Onyx Workout App
“With genetic engineering, we will be able to increase the complexity of our DNA, and improve the human race. But it will be a slow process, because one will have to wait about 18 years to see the effect of changes to the genetic code.”